- syngo BreVis enables a variety of new clinical functions for diagnostic reporting using syngo workplaces, which are also part of the new MAGNETOM Espree-Pink magnetic resonance breast scanner from Siemens
- syngo BreVis Biopsy simplifies planning for surgical interventions
- The software applications offer increased clinical efficiency through precise, streamlined workflows
- The software applications improve multi-modality diagnostics; ultrasound or radiography images can be viewed along with MR images
Bremen, September 4, 2009 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a software specialist for medical imaging, announced today the initial licensing of syngo BreVis and syngo BreVis Biopsy, diagnostic reporting and intervention software developed by MeVis BreastCare in a joint venture with Siemens.
The new MeVis BreastCare software applications are available through Siemens on syngo workplaces for all MAGNETOM magnetic resonance scanners – including MAGNETOM Espree-Pink, the dedicated breast scanner. This new MRI system from Siemens was specially designed for breast cancer diagnostics and is characterized in particular by its high comfort levels for patients. With 1.3 million incidences worldwide, breast cancer is the most frequently occurring tumor. In Germany and Europe, breast cancer represents almost 30 percent of all cancer cases.
“With syngo BreVis and syngo BreVis Biopsy, the MeVis experts have proven their extensive know-how extending to our clinical MR applications,” said Walter Märzendorfer, head of Magnetic Resonance, Siemens Healthcare. “Our flexible coil solution for the MAGNETOM Espree-Pink is ideally complemented by the workflow-oriented diagnostic reporting software from MeVis.”
The software applications are seamlessly integrated into the Siemens syngo platform and do not require a separate diagnostic workstation. They provide a range of important clinical functions that simplify the diagnostic evaluation of MR images for radiologists and, if necessary, removal of tissue samples when findings are ambiguous. All functions are clearly arranged as symbols on the process-oriented user interface according to the principle of tabbed browsing and are available immediately at the press of a button.
In addition to the various display modalities, syngo BreVis offers the opportunity for spontaneous post-processing of image data as well as various tools for enhanced diagnostic support. The diagnostic reporting software also includes features to further streamline clinical workflow. These include, for example, the automatic display of individual images during the image acquisition process.
Automatic image hanging – that is, the arrangement of images on the monitor – is based on the corresponding clinical process. This enables optimal inclusion into the clinical workflow. Using special computer algorithms, series of patient image data can be displayed in a suitable manner. For example, the wash-in and wash-out of contrast agent in tissue are visualized using color values.
Syngo BreVis supports the semi-automatic creation of diagnostic reports, including BI-RADS reports. The Breast Imaging Reporting and Data System (BI-RADS) developed by the American College of Radiology (ACR) enables a classification of diagnostic findings that can be subsequently stored in the respective hospital PACS systems (Picture Archiving and Communication Systems) and called up later as required.
The optional syngo BreVis Biopsy intervention software supports the planning of MR-guided biopsies, as well as the placement of guide wires to prepare for the resection of breast tumors. Based on a planning scan, the software automatically calculates the device coordinates for a positioning unit. The precise area of breast tissue to be sampled or removed via biopsy needle is reached in this way. The calculated coordinates are displayed graphically and numerically on-screen for easy printout. The software supports a range of popular positioning devices and biopsy needles from different manufacturers.
“We are very pleased with this important expansion of our partnership with Siemens in the area of magnetic resonance imaging,” said Dr. Carl J. G. Evertsz, Chairman of the Executive Board of MeVis Medical Solutions AG and President of the MeVis BreastCare joint venture with Siemens. “Together with the recently introduced diagnostic reporting software for the ACUSON S2000 automated ultrasound breast volume scanner and our many years of close cooperation in digital mammography and tomosynthesis with the syngo MammoReport product, we have moved a major step forward in the direction of real multi-modality diagnostics.”